Research Highlight

Targeted therapies: Strategies for mature T cell cancers

  • Subscribe to Nature Reviews Cancer for full access:

    $265

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

  1. 1.

    et al. PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis. Nature (2017)

  2. 2.

    et al. Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies. Nat. Med. (2017)

Download references

Author information

Affiliations

  1. Senior Editor, Nature Reviews Drug Discovery

    • Megan Cully

Authors

  1. Search for Megan Cully in: